touchENDOCRINOLOGY were delighted to speak to Jose Florez, Committee Chair for the ADA’s Scientific Sessions Meeting Planning Committee, about his highlights of the conference, organising such a large virtual platform, advances in genetics in patients with type 2 diabetes and gestational diabetes and how healthcare biobanks can accelerate clinical research.
1. What were your highlights of the 80th ADA 2020 Virtual Scientific Sessions? (0:06)
2. What was your experience organising a virtual conference of this size, and are you pleased with how it has turned out? (1:41)
3. Please summarise the research that you are involved in on genetics in patients with type 2 diabetes and gestational diabetes (3:09)
4. Please provide an overview of the benefits of healthcare biobanks and how they can accelerate clinical research (5:24)
Speaker disclosure: Jose Florez has received one honorarium from Novo Nordisk to speak at a scientific meeting on a topic of his choice.
Support: Interview commissioned and filming supported by Touch Medical Media.
Filmed in coverage of the ADA 2020 Virtual 80th Scientific Sessions
Share this Video
Related Videos In Diabetes
Matthew Budoff, ENDO 2021: Findings from a Substudy of the VERTIS CV Trial – Ertugliflozin for T2DM & ASCVD
We caught up with Professor Matthew Budoff (UCLA and Lundquist Institute, Torrance, CA, US) to discuss ertugliflozin in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease inadequately controlled with metformin and sulfonylurea (Clinical Trial Identifier: NCT01986881). ‘Efficacy and Safety of Ertugliflozin in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease […]
Insulin at 100: a life-saving discovery but more remains to be done
2021 marks the centenary of the discovery of insulin. It is important to remind ourselves that this life-saving medication still remains beyond the reach of many people with diabetes who need it. Find out more at: https://worlddiabetesday.org/about/insulin-at-100/ Support: Published in collaboration with the International Diabetes Federation.
Juliana Chan, EASD 2020 – COVID-19 and type 1 diabetes
We spoke with Prof. Juliana Chan (The Chinese University of Hong Kong, Hong Kong) following her session on COVID-19 and the impact on patients with type 1 diabetes. Questions What key areas of diabetes and COVID-19 were discussed at EASD 2020? (0:05) How do you think the COVID-19 pandemic has affected treatment both now and […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!